{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-025182","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2025-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.936823+00:00","generated_at":"2026-05-16T16:36:57.515497+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Immix Biopharma files updated auditor consents for S-3 registration","bullets":["Filed updated consents from former auditor KMJ Corbin and current auditor Crowe LLP, dated Nov 26, 2025.","Consents relate to audit reports on FY2024 financials included in Form 10-K filed Mar 25, 2025.","Consents are for incorporation into Registration Statement on Form S-3 (No. 333-290725)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-025182","json":"https://secwatch.observer/filing/0001493152-25-025182.json","markdown":"https://secwatch.observer/filing/0001493152-25-025182.md","text":"https://secwatch.observer/filing/0001493152-25-025182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225025182/0001493152-25-025182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315225025182/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T16:36:57.515497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}